Benjamin R. Yerxa, EVP & Chf, Research & Develop at INSPIRE PHARMACEUTICALS INC (ISPH), sold 2,000 shares at $5.55 ($11K) on 2010-01-04, disclosed to the SEC on 2010-01-05.
Scheduled sale ($11k) by EVP & Chf, Research & Develop under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.55 | 100 | $555 | 5.0% |
| 2 | $5.58 | 94 | $525 | 4.7% |
| 3 | $5.59 | 106 | $593 | 5.3% |
| 4 | $5.60 | 200 | $1K | 10.0% |
| 5 | $5.61 | 1,100 | $6K | 55.0% |
| 6 | $5.62 | 400 |
| $2K |
| 20.1% |
| Total | $5.61 avg | 2,000 | $11K | 100% |
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |